REPORT ID 4322

Global Xerostomia (Dry Mouth) Therapeutics Market Research Report 2017

Publish Date
18-Dec-17
Pages
116
Format
Electronic (PDF)

In this report, the global Xerostomia (Dry Mouth) Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Xerostomia (Dry Mouth) Therapeutics in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Xerostomia (Dry Mouth) Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    GlaxoSmithKline plc
    Church & Dwight Co., Inc.
    Colgate-Palmolive Company
    Hikma Pharmaceuticals PLC
    Pendopharm
    Sun Pharmaceuticals Industries Ltd.
    Lupin Pharmaceuticals, Inc.
    Pfizer, Inc.
    Parnell Pharmaceuticals, Inc.
    Acacia Pharma
    OraCoat
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Salivary Stimulants
    Salivary Substitutes
    Dentifrices
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    OTC
    Prescription

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Xerostomia (Dry Mouth) Therapeutics Market Research Report 2017
1 Xerostomia (Dry Mouth) Therapeutics Market Overview
    1.1 Product Overview and Scope of Xerostomia (Dry Mouth) Therapeutics
    1.2 Xerostomia (Dry Mouth) Therapeutics Segment by Type (Product Category)
        1.2.1 Global Xerostomia (Dry Mouth) Therapeutics Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Xerostomia (Dry Mouth) Therapeutics Production Market Share by Type (Product Category) in 2016
        1.2.3 Salivary Stimulants
        1.2.4 Salivary Substitutes
        1.2.5 Dentifrices
    1.3 Global Xerostomia (Dry Mouth) Therapeutics Segment by Application
        1.3.1 Xerostomia (Dry Mouth) Therapeutics Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 OTC
        1.3.3 Prescription
    1.4 Global Xerostomia (Dry Mouth) Therapeutics Market by Region (2012-2022)
        1.4.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Xerostomia (Dry Mouth) Therapeutics (2012-2022)
        1.5.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue Status and Outlook (2012-2022)
        1.5.2 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production Status and Outlook (2012-2022)

2 Global Xerostomia (Dry Mouth) Therapeutics Market Competition by Manufacturers
    2.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Xerostomia (Dry Mouth) Therapeutics Production and Share by Manufacturers (2012-2017)
    2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Xerostomia (Dry Mouth) Therapeutics Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Xerostomia (Dry Mouth) Therapeutics Market Competitive Situation and Trends
        2.5.1 Xerostomia (Dry Mouth) Therapeutics Market Concentration Rate
        2.5.2 Xerostomia (Dry Mouth) Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity and Market Share by Region (2012-2017)
    3.2 Global Xerostomia (Dry Mouth) Therapeutics Production and Market Share by Region (2012-2017)
    3.3 Global Xerostomia (Dry Mouth) Therapeutics Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Xerostomia (Dry Mouth) Therapeutics Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption by Region (2012-2017)
    4.2 North America Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.4 China Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.7 India Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)

5 Global Xerostomia (Dry Mouth) Therapeutics Production, Revenue (Value), Price Trend by Type
    5.1 Global Xerostomia (Dry Mouth) Therapeutics Production and Market Share by Type (2012-2017)
    5.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Type (2012-2017)
    5.3 Global Xerostomia (Dry Mouth) Therapeutics Price by Type (2012-2017)
    5.4 Global Xerostomia (Dry Mouth) Therapeutics Production Growth by Type (2012-2017)

6 Global Xerostomia (Dry Mouth) Therapeutics Market Analysis by Application
    6.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption and Market Share by Application (2012-2017)
    6.2 Global Xerostomia (Dry Mouth) Therapeutics Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Xerostomia (Dry Mouth) Therapeutics Manufacturers Profiles/Analysis
    7.1 GlaxoSmithKline plc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Church & Dwight Co., Inc.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Colgate-Palmolive Company
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Hikma Pharmaceuticals PLC
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Pendopharm
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Sun Pharmaceuticals Industries Ltd.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Lupin Pharmaceuticals, Inc.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Pfizer, Inc.
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Parnell Pharmaceuticals, Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Acacia Pharma
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 OraCoat

8 Xerostomia (Dry Mouth) Therapeutics Manufacturing Cost Analysis
    8.1 Xerostomia (Dry Mouth) Therapeutics Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Xerostomia (Dry Mouth) Therapeutics Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Xerostomia (Dry Mouth) Therapeutics Market Forecast (2017-2022)
    12.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2017-2022)
    12.2 Global Xerostomia (Dry Mouth) Therapeutics Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Xerostomia (Dry Mouth) Therapeutics Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer